Skip to content
10-K/A

Annual Report

JOUNCE THERAPEUTICS, INC.

0001640455-23-000066

← back to feed
Filed
Apr 28, 2023 12:00 AM ET
Period of report
—
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding restated FY 2022 · Mar 7, 2023 52.64M sh
Shares Diluted FY 2022 · Dec 31, 2022 51.68M sh
Shares Diluted FY 2022 · Dec 31, 2021 49.93M sh
Capex FY 2022 · Dec 31, 2022 $919K
Capex FY 2022 · Dec 31, 2021 $373K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$28.88M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$83.49M
Cash And Equivalents FY 2022 · Dec 31, 2022 $150.57M
Cash And Equivalents FY 2022 · Dec 31, 2021 $95.53M
Cash And Equivalents FY 2022 · Dec 31, 2020 $147.49M
Stockholders Equity FY 2022 · Dec 31, 2022 $183.11M
Stockholders Equity FY 2022 · Dec 31, 2021 $223.81M
Stockholders Equity FY 2022 · Dec 31, 2020 $211.29M
Current Liabilities FY 2022 · Dec 31, 2022 $23.57M
Current Liabilities FY 2022 · Dec 31, 2021 $18.9M
Total Liabilities FY 2022 · Dec 31, 2022 $29.44M
Total Liabilities FY 2022 · Dec 31, 2021 $28.89M
Current Assets FY 2022 · Dec 31, 2022 $197.23M
Current Assets FY 2022 · Dec 31, 2021 $190.83M
Total Assets FY 2022 · Dec 31, 2022 $212.55M
Total Assets FY 2022 · Dec 31, 2021 $252.7M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.99
Eps Diluted FY 2022 · Dec 31, 2021 −$1.82
Eps Basic FY 2022 · Dec 31, 2022 −$0.99
Eps Basic FY 2022 · Dec 31, 2021 −$1.82
Sga Expense FY 2022 · Dec 31, 2022 $30.97M
Sga Expense FY 2022 · Dec 31, 2021 $28.98M
Rd Expense FY 2022 · Dec 31, 2022 $103.27M
Rd Expense FY 2022 · Dec 31, 2021 $88.98M
Net Income FY 2022 · Dec 31, 2022 −$50.92M
Net Income FY 2022 · Dec 31, 2021 −$90.87M
Operating Income FY 2022 · Dec 31, 2022 −$52.24M
Operating Income FY 2022 · Dec 31, 2021 −$91.06M